Back

Welcome and introduction

30 August 2025 (12:30 - 12:35)
Organised by: Logo
Congress Presentation Part of: Therapy in action: optimising heart failure care with SGLT2 inhibitors for outpatients Chronic Heart Failure Open Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Biykem Bozkurt

Baylor College of Medicine, Houston (United States of America)

5 More presentations in this session

Presentation thumbnail
Why still talk about implementation of SGLT2 inhibitors?
Professor B. Bozkurt (Houston, US)
Presentation thumbnail
What are the barriers we need to break?
Professor P. Campbell (Newry, GB)
Presentation thumbnail
How do we identify patients with HFpEF?
Doctor C. Saldarriaga (Medellin, CO)
Presentation thumbnail
What are the wider benefits of SGLT2 inhibitors for cardio-renal-metabolic conditions?
Professor N. Marx (Aachen, DE)
Presentation thumbnail
Close
Professor B. Bozkurt (Houston, US)

Access the full session

Session thumbnail
Therapy in action: optimising heart failure care with SGLT2 inhibitors for outpatients
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Session
Bridging gaps in heart failure care: primary care trends, exercise, kidney function, and global health perspectives
thumbnail
Congress Session
Nursing and Allied Professions Investigator Award
thumbnail
Congress Session
Which device might help your HFpEF patient?

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources